Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance

Go back to Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance
(NASDAQ: EOLS) Delayed: 9.00 +0.03 (0.33%)
Previous Close $8.97    52 Week High
Open $8.86    52 Week Low
Day High $9.08    P/E N/A 
Day Low $8.86    EPS
Volume 918,135